APOE and amyloidosis: We have recently started to include the amyloid signature in our method involving the presence of three chaperone proteins (ApoE, SAP, ApoA-IV): as these are, however, physiologically present in the patients’ bloodstream, their presence is not necessarily an unequivocal marker of amyloidosis, but could merely indicate blood inclusions in bioptic specimens.